S-glutathionylation of UCP2, which is more ubiquitously expressed, was found to regulate insulin release by altering mitochondrial ROS release in pancreatic β-cells and sensitize drug resistant promyelocytic leukemia cells to chemotherapy [38,39]. Here, INS is linked to acute promyelocytic leukemia.